NVDA
NVIDIA Corporation
NVDA has the edge over SCSC overall, supported by stronger valuation and stronger fundamentals.
SCSC
ScanSource, Inc.
SCSC's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
SCSC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
SCSC's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over SCSC in the historical PE scenario, which offers more potential upside but is not a forecast.
SCSC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.7x | $27.69 | -37% |
| Forward | 8.9x | $44.26 | — |
| Fair | 13x | $42.03 | -5% |
| Current | 14x | $44.26 | — |
| Expensive | 17x | $52.71 | +19% |
Historical ranges are pointers, not guarantees.
SCSC's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 8.9x next year's earnings, in its cheap range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
SCSC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
SCSC has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over SCSC on earnings, with more consistent year-over-year improvement.
SCSC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.00 | +58% |
| Q3 2026 | $3.17 | -0.9% |
| Q2 2026 | $3.64 | +21% |
| Q1 2026 | $3.29 | +18% |
| Q4 2025 | $3.25 | +27% |
| Q3 2025 | $3.20 | +1.9% |
| Q2 2025 | $3.00 | -2% |
| Q1 2025 | $2.79 | -12% |
| Q4 2024 | $2.55 | -27% |
SCSC earned $3.17 per share over the past year, about the same as the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over SCSC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over SCSC on profitability, with a higher operating margin.
SCSC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $962.3M | +30% |
| Q2 2026 | $953.1M | +17% |
| Q1 2026 | $766.8M | +8.8% |
| Q4 2025 | $766.5M | +2.5% |
| Q3 2025 | $739.7M | -4.6% |
| Q2 2025 | $812.9M | +8.9% |
| Q1 2025 | $704.8M | -6.3% |
| Q4 2024 | $747.5M | -16% |
SCSC's revenue has grown year over year for four quarters in a row: $962M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.3% | -2.2 points |
| Q2 2026 | 3.3% | 0 points |
| Q1 2026 | 3% | -0.1 points |
| Q4 2025 | 2.3% | -0.1 points |
| Q3 2025 | 3.5% | +1.2 points |
| Q2 2025 | 3.3% | +0.4 points |
| Q1 2025 | 3.2% | +0.8 points |
| Q4 2024 | 2.5% | -0.6 points |
SCSC's operating margin was 1.3% last quarter, down 2.2 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over SCSC on cash flow, with more consistent year-over-year improvement.
SCSC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$44.1M | -312% |
| Q2 2026 | -$4.8M | -193% |
| Q1 2026 | $69M | +6.7% |
| Q4 2025 | $28.9M | +$37M |
| Q3 2025 | $20.8M | -51% |
| Q2 2025 | $5.1M | -90% |
| Q1 2025 | $64.6M | -59% |
| Q4 2024 | -$8.2M | -113% |
SCSC usually generates cash, though not every quarter: the latest was −$44M, but it generated $49M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
SCSC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.6% | -1M shares |
| 1 year | -7.7% | -1.7M shares |
| 3 years | -18% | -4.5M shares |
| 5 years | -20% | -5M shares |
| Available history | -18% | -4.7M shares |
SCSC has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.8M |
| Q2 2026 | $26.5M |
| Q1 2026 | $32.7M |
| Q4 2025 | $17.4M |
| Q3 2025 | $21.3M |
| Q2 2025 | $25.3M |
| Q1 2025 | $28.9M |
| Q4 2024 | $24.2M |
SCSC spent $81M buying back its own shares over the past year, down 18% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over SCSC on leverage, with a lower net debt burden relative to earnings.
SCSC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.3x | Very low |
SCSC's net debt is less than a year of its operating earnings (EBITDA).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
SCSC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.4 | Neutral |
| Stochastic | 24.2 | Neutral |
SCSC's weekly RSI is 37 (neutral) and its Stochastic is 24 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
SCSC PE vs Technology Sector
| Metric | SCSC | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 50% below |
| PE % | 53 | 35 | 18 pts above |
SCSC has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
SCSC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.9 | 21% below |
| 20 week MA | $55.5 | 20% below |
| 50 week MA | $46.8 | 5.4% below |
| 100 week MA | $43.8 | 1.1% above |
| 200 week MA | $41.0 | 7.9% above |
SCSC has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
SCSC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.6 | $26.2 | -28% |
| 2021 | $26.2 | $34.6 | +32% |
| 2022 | $34.6 | $29.1 | -16% |
| 2023 | $29.1 | $39.6 | +36% |
| 2024 | $39.6 | $47.8 | +21% |
| 2025 | $47.8 | $39.7 | -17% |
| 2026 YTD | $39.7 | $44.3 | +11% |
SCSC has the edge over NVDA on returns for 2026, with the stronger performance.